+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Otitis Media Drug"

Otitis media - Pipeline Insight, 2024 - Product Thumbnail Image

Otitis media - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Chronic Otitis Media - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Otitis Media - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
From
Otitis Media - Epidemiology Forecast to 2032 - Product Thumbnail Image

Otitis Media - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Otitis Media (COM) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Otitis Media (COM) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Otitis Media - Pipeline Review, H2 2020 - Product Thumbnail Image

Otitis Media - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 86 Pages
  • Global
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Otitis Media Drug is a type of Immune Disorders Drug used to treat inflammation of the middle ear. It is commonly used to treat acute otitis media, a bacterial infection of the middle ear. The drug works by reducing inflammation and swelling in the middle ear, which helps to reduce pain and discomfort. It is also used to prevent recurrent episodes of otitis media. Common side effects of Otitis Media Drug include nausea, vomiting, and diarrhea. The Otitis Media Drug market is a rapidly growing segment of the Immune Disorders Drugs market. It is driven by the increasing prevalence of otitis media, as well as the development of new and improved treatments. The market is expected to continue to grow in the coming years, as more effective treatments become available. Some companies in the Otitis Media Drug market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Sanofi. Show Less Read more